Established in 2015, Gaudium IVF and Women Health Limited is a premier provider of reproductive healthcare in India. The company operates through a strategic hub-and-spoke model, comprising 7 primary centers and 28 specialized “spoke” clinics. This expansive network allows Gaudium to maintain a presence in major urban centers, including Delhi, Mumbai, Bangalore, and Srinagar, while broadening access to fertility education and care across several states.

Gaudium offers a full spectrum of Assisted Reproductive Technology (ART), ranging from standard IVF and IUI to advanced male infertility treatments and high-risk pregnancy management. Beyond clinical procedures, the company provides holistic gynecological care for conditions like PCOS and endometriosis. With a reputation for excellence, Gaudium attracts a diverse international patient base from the UK, USA, and Africa, positioning itself as a global destination for specialized fertility solutions and maternal health.

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

(There are no listed peers of the company in the India.)

*Market cap @upper band

• Patient-Centric Approach
• Expert team
• Using next-gen INTEGRA Ti labs for ICSI.
• Highly Technical USG Guided Services
• Established central hubs in prime urban locations
• Asset Light Business Model

The Company GAUDIUM IVF & WOMEN HEALTH LIMITED IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

• Funding capital expenditure towards establishment of New IVF Centers of the Company (Rs. 50 Cr.)
• Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company (Rs. 20 Cr.)
• General Corporate Purpose

At the upper band of IPO Rs. 79, the stock is valued at 22.99 P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.